共 232 条
[1]
Pitout JD(2008)Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern Lancet Infect Dis 8 159-166
[2]
Laupland KB(1983)Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Infection 11 315-317
[3]
Knothe H(1989) and Antimicrob Agents Chemother 33 1131-1846
[4]
Shah P(2014)Extended-spectrum beta-lactamases Antimicrob Agents Chemother 58 1835-274
[5]
Krcmery V(2010)New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world J Glob Infect Dis 2 263-S23
[6]
Antal M(2003)Extended-spectrum beta-lactamases in Gram Negative Bacteria Clin Infect Dis 36 S11-301
[7]
Mitsuhashi S(2014)Bacterial resistance: origins, epidemiology, and impact Pathog Dis 71 292-67
[8]
Philippon A(2011): evolution of a global pathogen Clin Infect Dis 53 60-259
[9]
Labia R(2011)Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention Mayo Clin Proc 86 250-495
[10]
Jacoby G(2010)Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum β-lactamase—producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant J Antimicrob Chemother 65 490-252.e254